232 Chapter 8 87. Ding SC, Lo YMD. Cell-Free DNA Fragmentomics in Liquid Biopsy. Diagnostics (Basel). 2022;12(4). 88. Crisafulli G, Mussolin B, Cassingena A, Montone M, Bartolini A, Barault L, et al. Whole exome sequencing analysis of urine trans-renal tumour DNA in metastatic colorectal cancer patients. ESMO Open. 2019;4(6). 89. Mouliere F, Smith CG, Heider K, Su J, van der Pol Y, Thompson M, et al. Fragmentation patterns and personalized sequencing of cell-free DNA in urine and plasma of glioma patients. EMBO Mol Med. 2021;13(8):e12881. 90. Pol Yvd, Tantyo NA, Evander N, Hentschel AE, Ramaker J, Bahce I, et al. Real-time analysis of the cancer genome and fragmentome from plasma and urine short and long cell-free DNA using Nanopore sequencing. medRxiv. 2022:2022.08.11.22278674. 91. Cristiano S, Leal A, Phallen J, Fiksel J, Adleff V, Bruhm DC, et al. Genome-wide cell-free DNA fragmentation in patients with cancer. Nature. 2019;570(7761):385-9. 92. Snyder Matthew W, Kircher M, Hill Andrew J, Daza Riza M, Shendure J. Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin. Cell. 2016;164(1):5768. 93. Tsoneva DK, Ivanov MN, Conev NV, Manev R, Stoyanov DS, Vinciguerra M. Circulating Histones to Detect and Monitor the Progression of Cancer. Int J Mol Sci. 2023;24(2). 94. Yörüker EE, Holdenrieder S, Gezer U. Potential of circulating nucleosome-associated histone modifications in cancer. Transl Cancer Res. 2017;7(2):S185-91. 95. Zhao Z, Shilatifard A. Epigenetic modifications of histones in cancer. Genome Biology. 2019;20(1):245. 96. Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Research. 2011;21(3):381-95. 97. Bian B, Li L, Ke X, Chen H, Liu Y, Zheng N, et al. Urinary exosomal long non-coding RNAs as noninvasive biomarkers for diagnosis of bladder cancer by RNA sequencing. Frontiers in Oncology. 2022;12. 98. Li Y, Zheng Q, Bao C, Li S, Guo W, Zhao J, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Research. 2015;25(8):981-4. 99. Donkers H, Hirschfeld M, Weiß D, Erbes T, Jäger M, Pijnenborg J, et al. Detection of microRNA in urine to identify patients with endometrial cancer: a feasibility study. Int J Gynecol Cancer. 2021;31(6):868-74. 100. Záveský L, Jandáková E, Turyna R, Langmeierová L, Weinberger V, Záveská Drábková L, et al. Evaluation of cell-free urine microRNAs expression for the use in diagnosis of ovarian and endometrial cancers. A pilot study. Pathology & Oncology Research. 2015;21:1027-35. 101. He Y-D, Tao W, He T, Wang B-Y, Tang X-M, Zhang L-M, et al. A urine extracellular vesicle circRNA classifier for detection of high-grade prostate cancer in patients with prostate-specific antigen 2–10 ng/mL at initial biopsy. Molecular Cancer. 2021;20(1):96. 102. Li Y, Ji J, Lyu J, Jin X, He X, Mo S, et al. A Novel Urine Exosomal lncRNA Assay to Improve the Detection of Prostate Cancer at Initial Biopsy: A Retrospective Multicenter Diagnostic Feasibility Study. Cancers [Internet]. 2021; 13(16).
RkJQdWJsaXNoZXIy MjY0ODMw